Crosstalk of physiological pH and chemical pKa under the umbrella of physiologically based pharmacokinetic modeling of drug absorption, distribution, metabolism …

L Gaohua, X Miao, L Dou - Expert opinion on drug metabolism & …, 2021 - Taylor & Francis
Introduction: Physiological pH and chemical pKa are two sides of the same coin in defining
the ionization of a drug in the human body. The Henderson-Hasselbalch equation and pH …

Reverse translation in PBPK and QSP: going backwards in order to go forward with confidence

A Rostami‐Hodjegan - Clinical Pharmacology & Therapeutics, 2018 - Wiley Online Library
Significant events have taken place shaping the recent industrialization of physiologically
based pharmacokinetic in vitro–in vivo extrapolation (PBPK‐IVIVE) use in drug …

Systems toxicology: real world applications and opportunities

T Hartung, RE FitzGerald, P Jennings… - Chemical research in …, 2017 - ACS Publications
Systems Toxicology aims to change the basis of how adverse biological effects of
xenobiotics are characterized from empirical end points to describing modes of action as …

[HTML][HTML] Metformin and cimetidine: Physiologically based pharmacokinetic modelling to investigate transporter mediated drug–drug interactions

HJ Burt, S Neuhoff, L Almond, L Gaohua… - European journal of …, 2016 - Elsevier
Metformin is used as a probe for OCT2 mediated transport when investigating possible DDIs
with new chemical entities. The aim of the current study was to investigate the ability of …

Prediction of maternal and fetoplacental concentrations of cefazolin, cefuroxime, and amoxicillin during pregnancy using bottom-up physiologically based …

K Abduljalil, J Ning, A Pansari, X Pan… - Drug Metabolism and …, 2022 - ASPET
Concerns over maternal and fetal drug exposures highlight the need for a better
understanding of drug distribution into the fetus through the placental barrier. This study …

Development of a multicompartment permeability‐limited lung PBPK model and its application in predicting pulmonary pharmacokinetics of antituberculosis drugs

L Gaohua, J Wedagedera, BG Small… - CPT …, 2015 - Wiley Online Library
Achieving sufficient concentrations of antituberculosis (TB) drugs in pulmonary tissue at the
optimum time is still a challenge in developing therapeutic regimens for TB. A …

[HTML][HTML] Application of physiologically based kinetic (PBK) modelling in the next generation risk assessment of dermally applied consumer products

TE Moxon, H Li, MY Lee, P Piechota, B Nicol, J Pickles… - Toxicology in Vitro, 2020 - Elsevier
Abstract Next Generation Risk Assessment (NGRA) is a procedure that integrates new
approach methodologies (NAMs) to assure safety of a product without generating data from …

Towards quantitation of the effects of renal impairment and probenecid inhibition on kidney uptake and efflux transporters, using physiologically based …

V Hsu, M de LT Vieira, P Zhao, L Zhang… - Clinical …, 2014 - Springer
Abstract Background and Objectives The kidney is a major drug-eliminating organ. Renal
impairment or concomitant use of transporter inhibitors may decrease active secretion and …

Prediction of transporter‐mediated drug‐drug interactions for baricitinib

MM Posada, EA Cannady, CD Payne… - Clinical and …, 2017 - Wiley Online Library
Baricitinib, an oral selective Janus kinase 1 and 2 inhibitor, undergoes active renal tubular
secretion. Baricitinib was not predicted to inhibit hepatic and renal uptake and efflux drug …

Quantitative Translation of Microfluidic Transporter in Vitro Data to in Vivo Reveals Impaired Albumin-Facilitated Indoxyl Sulfate Secretion in Chronic Kidney Disease

TK Van Der Made, M Fedecostante… - Molecular …, 2019 - ACS Publications
Indoxyl sulfate (IxS), a highly albumin-bound uremic solute, accumulates in chronic kidney
disease (CKD) due to reduced renal clearance. This study was designed to specifically …